Clinical trial
A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of…
NCT00411398 · State University of New York - Upstate Medical University, Other · Completed
Key facts
| NCT number | NCT00411398 |
|---|---|
| Title | A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder |
| Official title | A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder (GAD) or Social Anxiety Disorder (SAD), Who Are Only Partial Responders to Selective Serotonin-Norepinephrine Reuptake Inhibitors… |
| Lead sponsor | State University of New York - Upstate Medical University, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | General Anxiety Disorder, Social Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Namenda/Memantine |
| Enrollment | 15 |
| Start date | Dec 1, 2006 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Dec 14, 2006 |
| Last update posted | Dec 10, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: